Diary: March 2008

NICE expects to consult on the following documents between 27 February and 25 March:

Scopes:

• Acute coronary syndromes (3/3/08)

Draft consultation:

• Attention Deficit Hyperactivity Disorder (31/01/08 – 27/03/08)
• Surgical repair of vaginal wall prolapse using mesh (26/02/08 – 27/03/08)
• Lumbar infusion test for the investigation of normal pressure hydrocephalus (26/02/08 – 27/03/08)
• Stent insertion for bleeding oesophageal varices (26/02/08 – 27/03/08)
• Transcatheter aortic valve implantation for aortic stenosis (26/02/08 – 27/03/08)
• Pulmonary arterial hypertension - epoprostenol, iloprost, treprostinil, beraprost, bosentan, & sildenafil (29/2/08 – 20/3/08)
• Smoking and children (5/03/08 - 7/04/08)
• Ulcerative colitis – infliximab (6/03/08 - 20/03/08)
• Rh-D negative women - routine antenatal anti-D prophylaxis (including new product rhophylac) (7/03/08 -1/04/08)
• Chronic kidney disease (11/3/08 - 6/5/08)

Other guidance development milestones between 27 February and 25 March:

Call for stakeholder registration:

• None

Stakeholder meetings:

• Critical illness rehabilitation (28/02/08)

Final scopes:

• None

Appeals to be heard:

• Rheumatoid arthritis – abatacept (17/03/08)
• Ankylosing spondylitis - adalimumab, etanercept and infliximab (31/03/08)

Consultation on synopsis of evidence:

• Diabetes - insulin pump therapy (29/02/08 – 14/03/08)
• Age-related macular degeneration (AMD) - pegaptanib and ranibizumab (20/03/08 – 11/04/08)